Search research articles
Contact Us
Filters
Showing results (461-470 of 537) with videos related to
Page
of 54
Sort By:
JCO Precision Oncology
|
February 16, 2022
Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma
Bradley A McGregor, Wanling Xie, Elio Adib, et al.
European Urology
|
July 16, 2019
Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect
Filippo Pederzoli, Marco Bandini, Alberto Briganti, et al.
Clinical Genitourinary Cancer
|
September 20, 2017
Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors
Jorge D Ramos, Jonathan T Wingate, Roman Gulati, et al.
Frontiers in Nephrology
|
September 7, 2023
A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design
Michelle N Rheault, Sandra Amaral, Margret Bock, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2018
Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (<i>CFH</i>) gene family
Stuart Cantsilieris, Bradley J Nelson, John Huddleston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2019
Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone
Rana R McKay, Huihui Ye, Wanling Xie, et al.
The Oncologist
|
April 3, 2019
The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer
Aristotelis Bamias, Kimon Tzannis, Christina Bamia, et al.
Environmental Microbiology
|
May 8, 2014
Comparative genome analysis of Pseudomonas knackmussii B13, the first bacterium known to degrade chloroaromatic compounds
Ryo Miyazaki, Claire Bertelli, Paola Benaglio, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward
L C Harshman, C G Drake, N B Haas, et al.
The Lancet. Neurology
|
December 21, 2010
Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial
Guy L Clifton, Alex Valadka, David Zygun, et al.
Page
of 54
Search research articles
Search
Showing results (461-470 of 537) with videos related to
Sort By:
Page
of 54
JCO Precision Oncology
|
February 16, 2022
Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma
Bradley A McGregor, Wanling Xie, Elio Adib, et al.
European Urology
|
July 16, 2019
Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect
Filippo Pederzoli, Marco Bandini, Alberto Briganti, et al.
Clinical Genitourinary Cancer
|
September 20, 2017
Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors
Jorge D Ramos, Jonathan T Wingate, Roman Gulati, et al.
Frontiers in Nephrology
|
September 7, 2023
A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design
Michelle N Rheault, Sandra Amaral, Margret Bock, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 25, 2018
Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (<i>CFH</i>) gene family
Stuart Cantsilieris, Bradley J Nelson, John Huddleston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2019
Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone
Rana R McKay, Huihui Ye, Wanling Xie, et al.
The Oncologist
|
April 3, 2019
The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer
Aristotelis Bamias, Kimon Tzannis, Christina Bamia, et al.
Environmental Microbiology
|
May 8, 2014
Comparative genome analysis of Pseudomonas knackmussii B13, the first bacterium known to degrade chloroaromatic compounds
Ryo Miyazaki, Claire Bertelli, Paola Benaglio, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward
L C Harshman, C G Drake, N B Haas, et al.
The Lancet. Neurology
|
December 21, 2010
Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial
Guy L Clifton, Alex Valadka, David Zygun, et al.
Page
of 54